Cargando…

Novel minimally invasive laser treatment of urinary incontinence in women

BACKGROUND AND OBJECTIVE: Urinary incontinence (UI) is a common disorder that affects women of various ages and impacts all aspects of life. Our aim was to evaluate the non‐invasive erbium:yttrium‐aluminum‐garnet (Er:YAG) laser that exploits its thermal effect and has been used in reconstructive and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogrinc, Urška B., Senčar, Sabina, Lenasi, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396289/
https://www.ncbi.nlm.nih.gov/pubmed/26388213
http://dx.doi.org/10.1002/lsm.22416
_version_ 1783230036666482688
author Ogrinc, Urška B.
Senčar, Sabina
Lenasi, Helena
author_facet Ogrinc, Urška B.
Senčar, Sabina
Lenasi, Helena
author_sort Ogrinc, Urška B.
collection PubMed
description BACKGROUND AND OBJECTIVE: Urinary incontinence (UI) is a common disorder that affects women of various ages and impacts all aspects of life. Our aim was to evaluate the non‐invasive erbium:yttrium‐aluminum‐garnet (Er:YAG) laser that exploits its thermal effect and has been used in reconstructive and rejuvenation surgery as a potential treatment strategy for stress UI (SUI) and mixed UI (MUI). STUDY DESIGN/MATERIALS AND METHODS: We included 175 women (aged 49.7 ± 10 years) with newly diagnosed SUI (66% of women) and MUI (34%), respectively. Patients were clinically examined and classified by incontinence types (SUI and MUI) and grades (mild, moderate, severe, and very severe) using International Consultation on Incontinence Modular Questionnaire (ICIQ) and assessing Incontinence Severity Index (ISI). Using Er:YAG laser, we performed on average 2.5 ± 0.5 procedures in each woman separated by a 2 month period. At each session, clinical examination was performed, ICIQ and ISI assessed and treatment discomfort measured with visual analog system (VAS) pain scale, and adverse effects and patients’ satisfaction were followed. Follow‐ups were performed at 2, 6, and 12 months after the treatment. RESULTS: After the treatment, ISI decreased for 2.6 ± 1.0 points in patients diagnosed with mild UI before the treatment, for 3.6 ± 1.4 points in those with moderate UI, for 5.7 ± 1.8 points in those with severe UI and for 8.4 ± 2.6 in those with very severe UI (P < 0.001, paired samples t‐test). Altogether, in 77% patients diagnosed with SUI, a significant improvement was found after treatment, while only 34% of women with MUI exhibited no UI at one year follow‐up. Age did not affect the outcome. No major adverse effects were noticed in either group. CONCLUSION: The results of our study, have shown that new non‐invasive Er:YAG laser could be regarded as a promising additional treatment strategy for SUI with at least one year lasting positive effects. On the other hand, it does not seem appropriate for treating MUI. Lasers Surg. Med. 47:689–697, 2015. © 2015 The Authors. Lasers in Surgery and Medicine Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-5396289
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53962892017-04-25 Novel minimally invasive laser treatment of urinary incontinence in women Ogrinc, Urška B. Senčar, Sabina Lenasi, Helena Lasers Surg Med Clinical Reports BACKGROUND AND OBJECTIVE: Urinary incontinence (UI) is a common disorder that affects women of various ages and impacts all aspects of life. Our aim was to evaluate the non‐invasive erbium:yttrium‐aluminum‐garnet (Er:YAG) laser that exploits its thermal effect and has been used in reconstructive and rejuvenation surgery as a potential treatment strategy for stress UI (SUI) and mixed UI (MUI). STUDY DESIGN/MATERIALS AND METHODS: We included 175 women (aged 49.7 ± 10 years) with newly diagnosed SUI (66% of women) and MUI (34%), respectively. Patients were clinically examined and classified by incontinence types (SUI and MUI) and grades (mild, moderate, severe, and very severe) using International Consultation on Incontinence Modular Questionnaire (ICIQ) and assessing Incontinence Severity Index (ISI). Using Er:YAG laser, we performed on average 2.5 ± 0.5 procedures in each woman separated by a 2 month period. At each session, clinical examination was performed, ICIQ and ISI assessed and treatment discomfort measured with visual analog system (VAS) pain scale, and adverse effects and patients’ satisfaction were followed. Follow‐ups were performed at 2, 6, and 12 months after the treatment. RESULTS: After the treatment, ISI decreased for 2.6 ± 1.0 points in patients diagnosed with mild UI before the treatment, for 3.6 ± 1.4 points in those with moderate UI, for 5.7 ± 1.8 points in those with severe UI and for 8.4 ± 2.6 in those with very severe UI (P < 0.001, paired samples t‐test). Altogether, in 77% patients diagnosed with SUI, a significant improvement was found after treatment, while only 34% of women with MUI exhibited no UI at one year follow‐up. Age did not affect the outcome. No major adverse effects were noticed in either group. CONCLUSION: The results of our study, have shown that new non‐invasive Er:YAG laser could be regarded as a promising additional treatment strategy for SUI with at least one year lasting positive effects. On the other hand, it does not seem appropriate for treating MUI. Lasers Surg. Med. 47:689–697, 2015. © 2015 The Authors. Lasers in Surgery and Medicine Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2015-09-21 2015-11 /pmc/articles/PMC5396289/ /pubmed/26388213 http://dx.doi.org/10.1002/lsm.22416 Text en © 2015 The Authors. Lasers in Surgery and Medicine Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Reports
Ogrinc, Urška B.
Senčar, Sabina
Lenasi, Helena
Novel minimally invasive laser treatment of urinary incontinence in women
title Novel minimally invasive laser treatment of urinary incontinence in women
title_full Novel minimally invasive laser treatment of urinary incontinence in women
title_fullStr Novel minimally invasive laser treatment of urinary incontinence in women
title_full_unstemmed Novel minimally invasive laser treatment of urinary incontinence in women
title_short Novel minimally invasive laser treatment of urinary incontinence in women
title_sort novel minimally invasive laser treatment of urinary incontinence in women
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396289/
https://www.ncbi.nlm.nih.gov/pubmed/26388213
http://dx.doi.org/10.1002/lsm.22416
work_keys_str_mv AT ogrincurskab novelminimallyinvasivelasertreatmentofurinaryincontinenceinwomen
AT sencarsabina novelminimallyinvasivelasertreatmentofurinaryincontinenceinwomen
AT lenasihelena novelminimallyinvasivelasertreatmentofurinaryincontinenceinwomen